{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T20:36:22Z","timestamp":1722803782573},"reference-count":22,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,1,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>T-cell acute lymphoblastic lymphomas commonly demonstrate activating Notch1 mutations as well as mutations or deletions in Fbxw7. However, because Fbxw7 targets Notch1 for degradation, genetic alterations in these genes are expected to be mutually exclusive events in lymphomagenesis. Previously, by using a radiation-induced Tp53-deficient mouse model for T-cell acute lymphoblastic lymphoma, we reported that loss of heterozygosity at the Fbxw7 locus occurs frequently in a Tp53-dependent manner. In the current study, we show that these thymic lymphomas also commonly exhibit activating Notch1 mutations in the proline-glutamic acid-serine-threonine (PEST) domain. Moreover, concurrent activating Notch1 PEST domain mutations and single-copy deletions at the Fbxw7 locus occur with high frequency in the same individual tumors, indicating that these changes are not mutually exclusive events. We further demonstrate that although Notch1 PEST domain mutations are independent of Tp53 status, they are completely abolished in mice with germline Fbxw7 haploinsufficiency. Therefore, Notch1 PEST domain mutations only occur when Fbxw7 expression levels are intact. These data suggest a temporal sequence of mutational events involving these important cancer-related genes, with Notch1 PEST domain mutations occurring first, followed by Fbxw7 deletion, and eventually by complete loss of Tp53.<\/jats:p>","DOI":"10.1182\/blood-2011-01-327619","type":"journal-article","created":{"date-parts":[[2011,11,24]],"date-time":"2011-11-24T02:36:56Z","timestamp":1322102216000},"page":"805-809","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":13,"title":["Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas"],"prefix":"10.1182","volume":"119","author":[{"given":"Kuang-Yu","family":"Jen","sequence":"first","affiliation":[{"name":"Department of Pathology, University of California\u2013San Francisco, San Francisco, CA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihn Young","family":"Song","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, University of California\u2013San Francisco, San Francisco, CA; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl Luke","family":"Banta","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, University of California\u2013San Francisco, San Francisco, CA; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, University of California\u2013San Francisco, San Francisco, CA; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Hua","family":"Mao","sequence":"additional","affiliation":[{"name":"Lawrence Berkeley National Laboratory, University of California\u2013Berkeley, Berkeley, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Balmain","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, University of California\u2013San Francisco, San Francisco, CA; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"5694","key":"2019111901004384100_B1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"issue":"2","key":"2019111901004384100_B2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood-2005-06-2553","article-title":"Activating Notch1 mutations in mouse models of T-ALL.","volume":"107","author":"O'Neil","year":"2006","journal-title":"Blood"},{"issue":"7147","key":"2019111901004384100_B3","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nature05886","article-title":"Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers.","volume":"447","author":"Maser","year":"2007","journal-title":"Nature"},{"issue":"12","key":"2019111901004384100_B4","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/MCB.01655-05","article-title":"Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes.","volume":"26","author":"Malecki","year":"2006","journal-title":"Mol Cell Biol"},{"issue":"38","key":"2019111901004384100_B5","doi-asserted-by":"crossref","first-page":"35847","DOI":"10.1074\/jbc.M103992200","article-title":"The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog.","volume":"276","author":"Oberg","year":"2001","journal-title":"J Biol Chem"},{"issue":"37","key":"2019111901004384100_B6","doi-asserted-by":"crossref","first-page":"34371","DOI":"10.1074\/jbc.M101343200","article-title":"Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor.","volume":"276","author":"Gupta-Rossi","year":"2001","journal-title":"J Biol Chem"},{"issue":"8","key":"2019111901004384100_B7","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.20070876","article-title":"FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors.","volume":"204","author":"O'Neil","year":"2007","journal-title":"J Exp Med"},{"issue":"8","key":"2019111901004384100_B8","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1084\/jem.20070872","article-title":"The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia.","volume":"204","author":"Thompson","year":"2007","journal-title":"J Exp Med"},{"issue":"12","key":"2019111901004384100_B9","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1158\/0008-5472.CAN-06-4381","article-title":"The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.","volume":"67","author":"Malyukova","year":"2007","journal-title":"Cancer Res"},{"issue":"16","key":"2019111901004384100_B10","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1158\/0008-5472.CAN-05-1664","article-title":"Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression.","volume":"65","author":"Beverly","year":"2005","journal-title":"Cancer Res"},{"issue":"4","key":"2019111901004384100_B11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cell.2008.03.021","article-title":"Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks.","volume":"133","author":"Uren","year":"2008","journal-title":"Cell"},{"issue":"7018","key":"2019111901004384100_B12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nature03155","article-title":"Fbxw7\/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.","volume":"432","author":"Mao","year":"2004","journal-title":"Nature"},{"issue":"19","key":"2019111901004384100_B13","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1158\/0008-5472.CAN-07-1320","article-title":"FBXW7\/hCDC4 is a general tumor suppressor in human cancer.","volume":"67","author":"Akhoondi","year":"2007","journal-title":"Cancer Res"},{"issue":"5895","key":"2019111901004384100_B14","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.1162981","article-title":"FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression.","volume":"321","author":"Mao","year":"2008","journal-title":"Science"},{"issue":"15","key":"2019111901004384100_B15","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1101\/gad.1450406","article-title":"c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia\/lymphoma.","volume":"20","author":"Weng","year":"2006","journal-title":"Genes Dev"},{"issue":"8","key":"2019111901004384100_B16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1349-7006.2006.00239.x","article-title":"Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation.","volume":"97","author":"Fujii","year":"2006","journal-title":"Cancer Sci"},{"issue":"26","key":"2019111901004384100_B17","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1200\/JCO.2009.22.0996","article-title":"Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII\/ECOG E2993 protocol.","volume":"27","author":"Mansour","year":"2009","journal-title":"J Clin Oncol"},{"issue":"17","key":"2019111901004384100_B18","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1182\/blood-2008-10-184069","article-title":"NOTCH1\/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.","volume":"113","author":"Asnafi","year":"2009","journal-title":"Blood"},{"issue":"53","key":"2019111901004384100_B19","doi-asserted-by":"crossref","first-page":"7924","DOI":"10.1038\/sj.onc.1208926","article-title":"Genomic instability in radiation-induced mouse lymphoma from p53 heterozygous mice.","volume":"24","author":"Mao","year":"2005","journal-title":"Oncogene"},{"issue":"2","key":"2019111901004384100_B20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ccr.2006.11.025","article-title":"Crosstalk between Aurora-A and p53: frequent deletion or downregulation of Aurora-A in tumors from p53 null mice.","volume":"11","author":"Mao","year":"2007","journal-title":"Cancer Cell"},{"issue":"25","key":"2019111901004384100_B21","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1182\/blood-2010-05-286328","article-title":"Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1.","volume":"116","author":"Ashworth","year":"2010","journal-title":"Blood"},{"issue":"38","key":"2019111901004384100_B22","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1038\/onc.2008.222","article-title":"It's T-ALL about Notch.","volume":"27","author":"Demarest","year":"2008","journal-title":"Oncogene"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/3\/805\/1464249\/zh800312000805.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/3\/805\/1464249\/zh800312000805.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T01:00:54Z","timestamp":1574125254000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/3\/805\/135122\/Sequential-mutations-in-Notch1-Fbxw7-and-Tp53-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,19]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,1,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-01-327619","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,19]]}}}